Form4.ai tracks every SEC insider trade in real time. See every IRD insider filing with a free account — no card.

See every IRD insider filing

Free account

Opus Genetics, Inc. (IRD) Insider Trading

Opus Genetics, Inc. (IRD) has 8 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 6 sales totalling $3.1M. Most recent filing: Oct. 27, 2026.

Bought vs sold

Open-market value, last 90 days

Sold: $3.1M (100%)
  • Sold $3.1M · 100%

What insiders filed

Form 4 filings by type, last 90 days

Sales: 6 (75%) Grants, exercises & other: 2 (25%)
  • Sales 6 · 75%
  • Grants, exercises & other 2 · 25%

At a glance

Insiders trading
6
Largest buy
—
Most recent filing
Oct 27, 2026

Latest IRD Form 4 filings

Date Insider Trade Value Price since buy
Oct 27, 2026 SEC filing SCHACHLE JOSEPH K Chief Operating Officer Sold $16,994 —
Oct 27, 2026 SEC filing YERXA BENJAMIN R President Sold $117,365 —
Oct 27, 2026 SEC filing Gagnon Robert E. Chief Financial Officer Sold $49,650 —

See every IRD insider trade

Create a free account to see all 8 IRD filings from the last 90 days. No card needed.

Create free account

Want IRD insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days

Insiders are buying right now in other stocks too. See the latest insider trades across the market.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.